Y-mAbs Therapeutics, Inc. (YMAB)

Sep 15, 2025 - YMAB was delisted (reason: acquired by SERB Pharmaceuticals)

8.61

+0.02 (0.23%)

Inactive · Last trade price on Sep 15, 2025

Y-mAbs Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	391	351	297	213	707	2,006
Market Cap Growth	-	17.88%	39.61%	-69.88%	-64.73%	61.56%
Enterprise Value	332	284	213	101	494	1,879
Last Close Price	8.61	7.83	6.82	4.88	16.21	49.51

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	4.54	4.00	3.51	3.27	20.27	96.67
PB Ratio	4.47	3.81	2.95	1.95	3.93	18.95
P/TBV Ratio	4.59	3.91	3.03	2.01	3.97	18.95

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
EV/Sales Ratio	3.89	3.24	2.51	1.54	14.16	90.55

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Debt / Equity Ratio	0.04	0.01	0.01	0.02	0.02	0.04
Asset Turnover	0.65	0.71	0.63	0.37	0.20	0.12
Inventory Turnover	1.74	2.48	1.94	1.24	-	-
Quick Ratio	3.40	3.67	5.02	4.18	6.79	5.87
Current Ratio	4.00	4.16	5.52	4.61	7.26	6.26
Return on Equity (ROE)	-24.31%	-30.74%	-20.39%	-66.06%	-38.66%	-78.32%
Return on Assets (ROA)	-8.67%	-12.67%	-9.84%	-29.40%	-41.84%	-43.03%
Return on Invested Capital (ROIC)	-12.09%	-16.08%	-12.41%	-35.34%	-49.15%	-48.21%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Earnings Yield	-5.68%	-8.46%	-7.20%	-44.85%	-7.81%	-5.95%
FCF Yield	-4.58%	-4.48%	-9.15%	-35.63%	-14.59%	-4.56%
Buyback Yield / Dilution	-2.79%	-1.57%	0.13%	-1.21%	-7.64%	-14.03%

SEC Filings: 10-K · 10-Q